Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae - a multicenter retrospective cohort study
C. Katada1
, M. Muto1
, K. Momma2
, M. Arima3
, H. Tajiri4
, C. Kanamaru4
, H. Ooyanagi5
, H. Endo6
, T. Michida7
, N. Hasuike8
, I. Oda8
, T. Fujii8
, D. Saito8
1Division of Digestive Endoscopy and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
2Department of Endoscopy, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
3Department of Gastroenterology, Saitama Cancer Center Hospital, Saitama, Japan
4Department of Endoscopy, The Jikei University School of Medicine, Tokyo, Japan
5Department of Diagnostic Imaging, Division of Endoscopy, Tochigi Cancer Center Hospital, Utsunomiya, Japan
6Department of Internal Medicine, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
7Department of Gastroenterology, Osaka National Hospital, Osaka, Japan
8Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan
Background and study aims: Endoscopic mucosal resection (EMR) is now commonly indicated for esophageal squamous cell carcinoma (ESCC) within the lamina propria mucosa. However, EMR for ESCC that has invaded the muscularis mucosa is controversial because the risk of lymph node metastasis is not negligible. We conducted a multicenter retrospective cohort study to investigate the incidence of lymph node metastasis and survival after EMR for ESCC invading the muscularis mucosa.
Patients and methods: A total of 104 patients with 111 lesions invading the muscularis mucosa, were retrospectively studied at eight institutes. No patients exhibited evidence of metastasis of lymph nodes or distant organs prior to EMR. Overall and cause-specific survival rates were calculated from the date of EMR to the date of death or the most recent follow-up visit. Survival curves were plotted according to the Kaplan-Meier method.
Results: In total, 86 patients (82.7 %) who did not receive further treatment such as chemotherapy, irradiation therapy, chemoradiotherapy, or esophagectomy after EMR were followed up. Only two patients (1.9 %) developed lymph node metastasis after EMR. With a median follow-up period of 43 months (range, 8 - 134 months), overall and cause-specific survival rates at 5 years after EMR were 79.5 % and 95.0 %, respectively.
Conclusions: EMR for ESCC that invades the muscularis mucosa has curative potential as a minimally invasive treatment option.
References
1
Yoshinaka H, Shimazu H, Fukumoto T. et al .
Superficial esophageal carcinoma: a clinicopathological review of 59 cases.
Am J Gastroenterol.
1991;
86
1413-1418
3
Nishimaki T, Tanaka O, Suzuki T. et al .
Tumor spread in superficial esophageal cancer: histopathologic basis for rational surgical treatment.
World J Surg.
1993;
17
766-771
5
Nagawa H, Kaizaki S, Seto Y. et al .
The relationship of macroscopic shape of superficial esophageal carcinoma to depth of invasion and regional lymph node metastasis.
Cancer.
1995;
75
1061-1064
6
Matsubara T, Ueda M, Abe T. et al .
Unique distribution patterns of metastatic lymph nodes in patients with superficial carcinoma of the thoracic oesophagus.
Br J Surg.
1999;
86
669-673
7
Tachibana M, Yoshimura H, Kinugasa S. et al .
Clinicopathological features of superficial squamous cell carcinoma of the esophagus.
Am J Surg.
1997;
174
49-53
8
Noguchi H, Naomoto Y, Kondo H. et al .
Evaluation of endoscopic mucosal resection for superficial esophageal carcinoma.
Surg Laparosc Endosc Percutan Tech.
2000;
10
343-350
9
Kodama M, Kakegawa T.
Treatment of superficial cancer of the esophagus: a summary of the responses to a questionnaire on superficial cancer of the esophagus in Japan.
Surgery.
1998;
123
432-439
10
Endo M, Yoshino K, Kawano T. et al .
Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus.
Dis Esoph.
2000;
13
125-129
11
Fujita H, Sueyoshi S, Yamana H. et al .
Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy.
World J Surg.
2001;
25
424-431
12
Buskens C J, Westerterp M, Lagarde S M. et al .
Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features.
Gastrointest Endosc.
2004;
60
703-710
13
Araki K, Ohno S, Egashira A. et al .
Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis.
Cancer.
2002;
94
570-575
14
Momma K, Sakaki N, Yoshida M.
Endoscopic mucosectomy for precise evaluation and treatment of esophageal intraepithelial cancer [in Japanese with English abstract].
Endoscopia Digestiva.
1990;
2
501-506
19 Japanese Society for Esophageal Disease .Guidelines for clinical and pathologic studies on carcinoma of the esophagus (in Japanese). 9th edn. Tokyo; Kanehara Shuppan 1999
20
Lightdale C J, Lambert R.
The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon.
Gastrointest Endosc.
2003;
58 (6 Suppl)
S3-S43
24
Oyama T, Miyata Y, Shimatani S. et al .
Lymph nodal metastasis of m3, sm1 esophageal cancer (in Japanese with English abstract).
I to Cho.
2002;
37
71-74
25
Shimizu Y, Tsukagoshi H, Fujita M. et al .
Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper.
Gastrointest Endosc.
2002;
56
387-390
